dalfampridine
dalfampridine is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: powder.
Drug details
- Generic Name
- dalfampridine
- Sponsor
- Jubilant Biosys Limited
- NDC Codes
- 1
- Dosage Forms
- POWDER
- Active Ingredients
- DALFAMPRIDINE
Indications and Usage
1 INDICATIONS AND USAGE Dalfampridine extended-release tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed [see Clinical Studies (14) ]. Dalfampridine is a potassium channel blocker indicated to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed ( 1 , 14 ).